Diffuse pulmonary infiltrates in immunocompromised patients.
The differential diagnosis of bilateral interstitial pulmonary infiltrates in immunocompromised patients is very extensive. We describe two immunocompromised patients with diffuse pulmonary infiltrative changes. Bronchoscopic bronchoalveolar lavage after orotracheal intubation using topical anaesthesia combined with mild sedation in an ICU setting is safe in critically ill patients and often yields a conclusive diagnosis.
Fijen
J W
JW
Intensive Care Beademing, Interne Kliniek, Academisch Ziekenhuis, Groningen, The Netherlands. j.w.fijen@int.azg.nl
van der Werf
T S
TS
Ligtenberg
J J
JJ
Tulleken
J E
JE
Zijlstra
J G
JG
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000276:immunology*; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology*; D001999:Bronchoscopy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000276:immunology* / Q000628:therapy; D008297:Male; D012131:Respiratory Insufficiency / Q000209:etiology*; D012769:Shock / Q000209:etiology*; D016896:Treatment Outcome
D000970:Antineoplastic Agents